Products for Research Use Only
RegisterLogin

CDK9-IN-45

CAT: 0804-HY-179023Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-179023Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CDK9-IN-45 (Compound B11) is a highly selective CDK9 inhibitor with IC50 values for CDK9 and CDK1 of 7.13 and 489.5 nM respectively. CDK9-IN-45 exhibits a potent inhibitory effect on colorectal cancer cells. CDK9-IN-45 induces cell apoptosis and leads to significant accumulation of ROS. CDK9-IN-45 activates Caspase-3, downregulates Mcl-1, XIAP, and c-Myc. CDK9-IN-45 can be used for research on colorectal cancer[1].
Target
Apoptosis; Bcl-2 Family; Caspase; CDK; c-Myc; IAP; Reactive Oxygen Species (ROS)
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Field of Research
Cancer
Smiles
FC1=CC=C(C2=CC=NC(NC3=CC(NN=C4C(N5CC6(COC6)C5)=O)=C4C=C3)=C2)C(OC)=C1
Molecular Formula
C25H22FN5O3
Molecular Weight
459.47
References & Citations
[1]Sun X, et al. Design, synthesis, and activity evaluation of selective CDK9 inhibitors containing indazole fragments. Bioorg Chem. 2025 Oct 13;166:109083.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Caspase 3; CDK1; CDK9; Mcl-1; XIAP

Related Products

CatalogName
HY-172872CDK2-IN-45
HY-173481CDK9-IN-37
HY-130852-01CDK9-IN-11
HY-157980CDK9-IN-32
HY-155153CDK9-IN-24
HY-160171CDK9-IN-31
HY-115714-01CDK9-IN-12
HY-143585-01CDK9-IN-14
HY-176736CDK9-IN-40
HY-126251-01CDK9-IN-7

Alternative Products

CatalogName
030081CDK9
GTR18308618CDK9-55/CDK9 Rabbit Polyclonal Antibody
GTR18187313CDK9 Antibody
BA3838-50CDK9-IN-10
BA3826-1CDK9-IN-13
BA2986-1CDK9-IN-7
BA3853-10CDK9-IN-14
T205526-01CDK9-IN-36
T201179-01CDK9-IN-35
T63490-01CDK9-IN-19

Popular Products